Trade Ionis Pharmaceuticals, Inc. - IONS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.23 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 31.41 |
| Open | 31.67 |
| 1-Year Change | -37.79% |
| Day's Range | 31.38 - 32.74 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | 32.50 | 1.20 | 3.83% | 31.30 | 32.88 | 31.27 |
| Jan 17, 2025 | 31.26 | -0.37 | -1.17% | 31.63 | 32.41 | 31.26 |
| Jan 16, 2025 | 32.21 | -0.75 | -2.28% | 32.96 | 33.22 | 32.10 |
| Jan 15, 2025 | 32.98 | -0.02 | -0.06% | 33.00 | 33.62 | 32.59 |
| Jan 14, 2025 | 32.63 | -2.49 | -7.09% | 35.12 | 35.12 | 32.45 |
| Jan 13, 2025 | 34.85 | 1.50 | 4.50% | 33.35 | 35.09 | 32.64 |
| Jan 10, 2025 | 33.39 | -0.06 | -0.18% | 33.45 | 33.59 | 33.09 |
| Jan 8, 2025 | 33.93 | -0.50 | -1.45% | 34.43 | 34.60 | 33.93 |
| Jan 7, 2025 | 34.79 | 0.93 | 2.75% | 33.86 | 35.34 | 33.72 |
| Jan 6, 2025 | 33.93 | -0.83 | -2.39% | 34.76 | 34.98 | 33.74 |
| Jan 3, 2025 | 34.61 | 0.24 | 0.70% | 34.37 | 35.15 | 34.37 |
| Jan 2, 2025 | 34.60 | -0.41 | -1.17% | 35.01 | 35.39 | 34.00 |
| Dec 31, 2024 | 34.80 | 0.32 | 0.93% | 34.48 | 35.52 | 34.48 |
| Dec 30, 2024 | 34.75 | -0.48 | -1.36% | 35.23 | 35.42 | 34.58 |
| Dec 27, 2024 | 35.86 | 0.27 | 0.76% | 35.59 | 36.78 | 35.59 |
| Dec 26, 2024 | 36.26 | 0.41 | 1.14% | 35.85 | 36.53 | 35.46 |
| Dec 24, 2024 | 36.32 | 0.94 | 2.66% | 35.38 | 36.68 | 35.38 |
| Dec 23, 2024 | 36.00 | 0.62 | 1.75% | 35.38 | 36.50 | 35.38 |
| Dec 20, 2024 | 35.56 | -0.06 | -0.17% | 35.62 | 36.26 | 34.86 |
| Dec 19, 2024 | 35.49 | -0.88 | -2.42% | 36.37 | 36.68 | 35.32 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Ionis Pharmaceuticals Company profile
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein. It is also developing inotersen, an antisense drug Ionis to treat patients with hereditary transthyretin amyloidosis; and volanesorsen, an antisense drug for the treatment of familial chylomicronemia syndrome and familial partial lipodystrophy. In addition, the company is developing drugs for various indications, such as cardiometabolic diseases caused by lipid disorders; cardiovascular disease, clotting disorders, and Alzheimer's and Parkinson's diseases; and acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington's disease. Ionis Pharmaceuticals, Inc. has a collaboration agreement with AstraZeneca to discover and develop antisense therapies for treating cardiovascular and metabolic diseases, and cancer; and Biogen Inc. to develop and commercialize therapies for neurological disorders, SMA, and neurodegenerative diseases. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, California.| Industry: | Biotechnology & Medical Research (NEC) |
2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 680,000+ traders worldwide that chose to trade with Capital.com